News

Keep up with the latest news from the NCI Center for Biomedical Informatics and Information Technology (CBIIT) and the data science communities.

Learn about NCI’s LORIS, a new artificial intelligence-approach to help you predict how a patient will respond to immunotherapy.

Can you develop an algorithm that applies to every patient, in every situation? A recent study shows the importance of adding diversity to your data when developing AI models.

See how NCI researchers are using artificial intelligence to develop tools that may someday help oncologists make more informed decisions when caring for people with prostate cancer.

NCI-funded researchers are using machine learning to help identify an early-warning screening approach for colorectal cancer.

Want to identify existing gene mutations more accurately and discover new signatures more efficiently? There’s a new NCI-funded tool, the Mutational Signature Calculator, that can help improve your standard workflow.

Dr. Jill Barnholtz-Sloan is CBIIT’s new acting director following Dr. Tony Kerlavage’s retirement last week. In addition to this role, Dr. Barnholtz-Sloan maintains her responsibility as associate director for the Informatics and Data Science Program and senior investigator in the Division of Cancer Epidemiology and Genetics, Trans-Divisional Research Program.

CAFCW24 is an opportunity to collaborate with experts in data science, computational biology, artificial intelligence (AI), computer science, and other disciplines to drive cancer research and innovation.

Are you researching immunotherapies and having trouble predicting which epitope will deliver the biggest punch? Try this new model for predicting immunogenicity, which is reportedly outperforming current models.

See the digital health technologies informed consent resource that your Request for Information responses helped create!

In the “Mitelman Gene Fusions in TCGA” notebook, ISB Cancer Gateway in the Cloud (an NCI Cloud Resource) identified the most common gene fusions in prostate adenocarcinoma, demonstrating machine learning in Google BigQuery.